Histopathological bronchial reconstruction of human bronchiolitis obliterans

Pathology International

Volumn 61, Issue 4, 2011, Pages 192-201

  Sugino, Keishi ^a   Hebisawa, Akira ^b   Uekusa, Toshimasa ^d   Hatanaka, Kazuhito ^e   Abe, Hiroshi ^c   Homma, Sakae ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^b TOKYO NATIONAL HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KANTO ROSAI HOSPITAL   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Bronchiolitis obliterans; Cellular destructive bronchiolitis obliterans; Constrictive bronchiolitis obliterans; Histopathological bronchial reconstruction

Indexed keywords

CORTICOSTEROID; MACROLIDE;

ADOLESCENT; ADULT; AGED; AIRWAY; ARTICLE; AUTOPSY; BRONCHIOLE; BRONCHIOLITIS OBLITERANS; BRONCHOSPASM; BRONCHUS; BRONCHUS OBSTRUCTION; CLINICAL ARTICLE; DISEASE CLASSIFICATION; FEMALE; FIBROSIS; HISTOPATHOLOGICAL BRONCHIAL RECONSTRUCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; MORPHOLOGY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; BRONCHI; BRONCHIOLITIS OBLITERANS; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79952814946     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2010.02637.x     Document Type: Article

References (25)

1. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002; 166: 440-4.
2. Estenne M, Maurer JR, Boehler A etal. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
3. Hollmén M, Tikkanen JM, Nykänen AI, Koskinen PK, Lemström KB. Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development. J Heart Lung Transplant 2008; 27: 856-64.
4. Hachem RR, Yusen RD, Chakinala MM etal. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. J Heart Lung Transplant 2007; 26: 1012-18.
5. Gottlieb J, Szangolies J, Koehnlein T, Golpon H, Simon A, Welte T. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2008; 85: 36-41.
6. Smith C, Jaramillo A, Lu KC, Kaleem Z, Patterson G, Mohanakumar T. Neutralization of tumor necrosis factor-alpha or interleukin-1 prevents obliterative airway disease in HLA-A2 transgenic murine tracheal allografts. J Heart Lung Transplant 2001; 20: 166-7.
7. Belperio JA, Keane MP, Burdick MD etal. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest 2001; 108: 547-56.
8. Aris RM, Walsh S, Chalermskulrat W, Hathwar V, Neuringer IP. Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am J Respir Crit Care Med 2002; 166: 417-22.
9. Hübner RH, Meffert S, Mundt U etal. Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J 2005; 25: 494-501.
10. Belperio JA, Keane MP, Burdick MD etal. CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury. J Immunol 2005; 175: 6931-9.
11. Ward C, Forrest IA, Murphy DM etal. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 2005; 60: 865-71.
12. Colby TV, Myers JL. Clinical and histologic spectrum of bronchiolitis obliterans, including bronchiolitis obliterans organizing pneumonia. Semin. Respir Med 1992; 13: 119-33.
13. King TE Jr. Bronchiolitis. In: Schwarz MI, King TE Jr, eds. Interstitial Lung Disease, 4th edn. Hamilton: B.C. Decker, Inc, 2003; 787-824.
14. Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med 2003; 168: 1277-92.
15. Geddes DM, Corrin B, Brewerton DA, Davies RJ, Turner-warwick M. Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med 1977; 184: 427-44.
16. Lai RS, Chiang AA, Wu MT etal. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 1996; 348: 83-5.
17. Sugino K, Hebisawa A, Uekusa T, Homma S. Bronchiolitis obliterans associated with chronic graft versus host disease after bone marrow transplant -comparison of histopathological bronchial reconstruction with bronchiolitis obliterans associated with rheumatoid arthritis- (in Japanese). Ther Res 2008; 29: 21-5.
18. Homma S, Sakamoto S, Kawabata M etal. Comparative clinicopathology of obliterative bronchiolitis and diffuse panbronchiolitis. Respiration 2006; 73: 481-7.
19. Yokoi T, Hirabayashi N, Ito M etal. Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: A clinicopathological study of eight autopsy cases. Virchows Arch 1997; 431: 275-82.
20. Yamanaka A, Maeda M, Yamamoto R. Chronic obstractive bronchiolitis -including bronchobronchiolitis obliterans- (in Japanease). Nihon Kyobu Rinsho 1986; 45: 539-54.
21. Hebisawa A, Baba M, Yasuda K, Tamura A. Pathology of diffuse bronchiectasis (in Japanese). Pathol Clin Med 2002; 20: 898-903.
22. Valentine VG, Gupta MR, Walker JE Jr etal. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2009; 28: 163-9.
23. Maeda M, Saiki S, Yamanaka A. Serial section analysis of the lesions in diffuse panbronchiolitis. Acta Pathol Jpn 1987; 37: 693-704.
24. Nicod LP. Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc 2006; 3: 444-9.
25. Belperio JA, Weigt SS, Fishbein MC, Lynch JP 3rd. Chronic lung allograft rejection: Mechanisms and therapy. Proc Am Thorac Soc 2009; 6: 108-21.